Richardson Electronics (RELL) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
2 Feb, 2026Executive summary
Fiscal 2024 was challenging with a 25.2% decline in net sales to $196.5 million, driven by weak semiconductor wafer fab demand, GES program delays, and economic headwinds, but the company focused on margin improvement, inventory reduction, and strategic investments.
Achieved milestones in wind turbine generator module sales, expanded GES customer base, and launched new locomotive starter modules.
Healthcare sales grew, and management prioritized gross margin improvement, inventory reduction, and maintaining a strong balance sheet with $24.3 million in cash and no debt.
Board declared a $0.06 per share quarterly cash dividend.
Financial highlights
Fiscal 2024 net sales were $196.5 million, down from $262.7 million in fiscal 2023; Q4 net sales were $47.4 million, down from $58.8 million year-over-year.
Fiscal 2024 net income was $0.1 million (EPS: $0.00), down from $22.3 million (EPS: $1.55) in fiscal 2023; non-GAAP net income was $0.5 million (non-GAAP EPS: $0.03).
Q4 net loss was $0.1 million (EPS: -$0.01); non-GAAP net income was $0.3 million (non-GAAP EPS: $0.02).
Gross margin for fiscal 2024 was 30.5%, down from 31.9% in fiscal 2023; Q4 gross margin improved to 31.1% from 27.9% year-over-year.
Generated $7.2 million in Q4 operating cash flow; year-end cash and equivalents were $24.3 million.
Outlook and guidance
Management expects sequential and year-over-year growth in semiconductor wafer fab and green energy businesses in FY 2025, with a stronger second half and higher profitability.
Anticipate margin stability as engineered solutions grow; backlog and bookings support optimism for FY 2025.
Long-term strategies focus on high-growth, higher-margin opportunities and diversification.
Healthcare division evaluating strategic options, aiming for improved profitability as new tube repair opportunities open.
Latest events from Richardson Electronics
- Q1 FY25 sales up 2.2% to $53.7M, with GES and Healthcare growth and a strong, debt-free balance sheet.RELL
Q1 202519 Jan 2026 - Q3 net sales up 2.7% YoY, strong PMT/Canvys, $4.9M Healthcare loss, cash $36.7M, no debt.RELL
Q3 202516 Jan 2026 - Q2 FY25 sales up 12.1% to $49.5M, led by 129% GES growth and improved margins.RELL
Q2 202510 Jan 2026 - Q2 FY26 sales up 5.7% to $52.3M, GES up 39%, net loss narrows, $0.06 dividend declared.RELL
Q2 20268 Jan 2026 - Shareholders will vote on director elections, auditor ratification, compensation, and capital structure changes.RELL
Proxy Filing1 Dec 2025 - Proxy seeks approval for director elections, auditor, compensation, and share increases.RELL
Proxy Filing1 Dec 2025 - Director elections, auditor ratification, and executive pay are key 2024 meeting topics.RELL
Proxy Filing1 Dec 2025 - Annual meeting to elect directors, ratify auditor, and approve executive pay on October 8, 2024.RELL
Proxy Filing1 Dec 2025 - Definitive proxy statement filed for shareholder voting, with no fee required.RELL
Proxy Filing1 Dec 2025